Uses of Agi bromhexine

Agi Bromhexine is an oral solution with the main ingredient Bromhexin that works to dilute secretions and transport secretions in the bronchial tract to facilitate expectoration and cough.

Agi-Bromhexine Agimex 60ml is a liquid medicine with the main ingredient being Bromhexine, which has the effect of thinning sputum in acute and chronic bronchopulmonary diseases.

Agi-Bromhexine is indicated for the treatment of sputum thinning in acute and chronic bronchopulmonary diseases accompanied by abnormal mucus secretion and impaired mucus transport.

Agi-Bromhexine is contraindicated in the following cases:
Hypersensitivity to Bromhexin hydrochloride and any other ingredients in the drug. Patients with rare genetic conditions that may be incompatible with any of the excipients of the drug.

Usage: The drug is taken orally.
Dosage
Adults and children over 12 years old: 10ml x 3 times/day. Children 6-12 years old: 5ml x 3 times/day. Children 2 - 6 years old: 2.5ml x 3 times/day. Children under 2 years old: 1.25ml x 3 times/day. At the start of treatment it may be necessary to increase the total daily dose to 48 mg (60 ml or 20 ml 3 times daily) in adults and children over 12 years of age.
Patients treated with Agi-bromhexine should be aware of the potential for increased secretions.
The duration of treatment with Agi-bromhexine should not exceed 8-10 days without consulting a doctor.
Note: To get the right dose for the condition and progression of the disease, it is necessary to consult a doctor.

When using Agi-Bromhexine, you may experience unwanted effects such as: Nausea, vomiting, upper abdominal pain, diarrhea, hypersensitivity, rash.

There have been very few reports of serious skin lesions such as Stevens-Johnson syndrome and transient toxic epidermal necrolysis due to the use of Bromhexin. The majority of cases were explained by the patient's underlying medical condition and/or concomitant medication. Patients should consult a doctor immediately and stop treatment with Bromhexin if some new lesions on the skin or mucous membranes appear. The drug contains Sorbitol, which can cause unpleasant digestive symptoms and has a mild laxative effect. The drug should not be used in patients with rare hereditary problems of fructose intolerance. Caution should be exercised when Agi-bromhexine and other cough suppressants are co-administered to avoid accumulation of secretions due to impaired cough reflex, and combinations should be made only after an assessment of the benefits and risks. Use with caution in patients with gastric ulcer. Use with caution in asthmatic patients because Bromhexine can cause bronchospasm. Extreme caution must be exercised when using the drug in patients with severe renal or hepatic impairment. Use with caution in patients who are elderly, debilitated or too weak to produce sputum. Ability to drive and use machines: No effect on the ability to drive and use machines has been observed. Pregnant women: There are limited data on the use of the drug in pregnant women. Women of childbearing potential or using birth control methods should consult their doctor before taking this medicine. Lactation: It is not known whether Bromhexin/metabolites are excreted in human milk. The drug should not be used while breastfeeding.